John Harry Cross III - 15 Dec 2021 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chief Financial Officer
Signature
/s/ John Harry Cross III, power of attorney
Issuer symbol
SONN
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
4
Filing time
08 Apr 2022, 16:30:38 UTC
Next filing
22 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Award +66,951 +86% 145,165 15 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 15, 2021, the Reporting Person was granted 66,951 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.
F2 Includes unvested RSUs.